Enzon Pharmaceuticals Inc (NASDAQ:ENZN) Still on Royalty-Driven Autopilot
[[tagnumber 0]][[tagnumber 1]]Enzon Pharmaceuticals Inc (NASDAQ:ENZN) published a 10–Q report for the quarter ended Mar. 31, 2015 last week, only a few weeks after ENZN hit a 52–week high on the charts, became overbought...